A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma

Alexander C. Huang, Robert J. Orlowski, Xiaowei Xu, Rosemarie Mick, Sangeeth M. George, Patrick K. Yan, Sasikanth Manne, Adam A. Kraya, Bradley Wubbenhorst, Liza Dorfman, Kurt D’Andrea, Brandon M. Wenz, Shujing Liu, Lakshmi Chilukuri, Andrew Kozlov, Mary Carberry, Lydia Giles, Melanie W. Kier, Felix Quagliarello, Suzanne McGettiganKristin Kreider, Lakshmanan Annamalai, Qing Zhao, Robin Mogg, Wei Xu, Wendy M. Blumenschein, Jennifer H. Yearley, Gerald P. Linette, Ravi K. Amaravadi, Lynn M. Schuchter, Ramin S. Herati, Bertram Bengsch, Katherine L. Nathanson, Michael D. Farwell, Giorgos C. Karakousis, E. John Wherry, Tara C. Mitchell

Research output: Contribution to journalArticlepeer-review

311 Scopus citations

Fingerprint

Dive into the research topics of 'A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds